Dennis Karl Huang

Insider Reports History

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dennis Karl Huang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Officer Common Stock 115K $4.92M $42.92 Mar 3, 2025 Direct
Ultragenyx Pharmaceutical Inc. Officer Stock Option (Right to Buy) 26.1K Mar 1, 2025 Direct

Insider Reports Filed by Dennis Karl Huang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2025 4 -$57.9K 4 Mar 4, 2025 Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 4 -$25.2K 4 Mar 5, 2024 EVP, Chief Technical Operations Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 5 -$502K 4 Mar 3, 2023 EVP, Chief Technical Operations Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$215K 4 Mar 3, 2022 EVP, Chief Technical Operations Officer and Gene Therapy Operations
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$29K 4 Oct 18, 2021 EVP & Chief Tech Ops Officer
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$41.3K 4 May 10, 2021 EVP & Chief Tech Ops Officer